Helicobacter pylori gastritis and gastric physiology

K E L McColl, E El-Omar, D Gillen

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

It is now recognized that Helicobacter pylori infection exerts profound and diverse effects on gastric acid secretory function and that the alterations in acid secretion depend on the pattern of gastritis caused by the infection. In patients with an antral predominant nonatrophic gastritis, there is acid hypersecretion leading to duodenal ulcer disease. In patients with an atrophic pangastritis, there is markedly reduced acid secretion and increased risk for gastric cancer. It is now recognized that acid secretion also modifies H. pylori gastritis and a person's premorbid acid secretory status may be an important factor in determining the pattern of gastritis that an individual develops. This two-way interaction between H. pylori gastritis and gastric acid secretion is important in understanding the role of H. pylori infection in the response to proton-pump inhibitor therapy: It explains the more profound control of gastric acid secretion in H. pylori-positive patients and why rebound acid hypersecretion is confined to H. pylori-negative subjects.

Original languageEnglish
Pages (from-to)687
Number of pages18
JournalGastroenterology Clinics of North America
Volume29
Publication statusPublished - 2000

Keywords

  • DUODENAL-ULCER PATIENTS
  • ACID SUPPRESSIVE THERAPY
  • NECROSIS-FACTOR-ALPHA
  • ANTRAL GASTRIN
  • INTRAGASTRIC PH
  • LONG-TERM
  • SOMATOSTATIN CONCENTRATIONS
  • CAMPYLOBACTER PYLORI
  • HEALTHY-SUBJECTS
  • IN-VITRO

Cite this

McColl, K. E. L., El-Omar, E., & Gillen, D. (2000). Helicobacter pylori gastritis and gastric physiology. Gastroenterology Clinics of North America, 29, 687.

Helicobacter pylori gastritis and gastric physiology. / McColl, K E L ; El-Omar, E ; Gillen, D .

In: Gastroenterology Clinics of North America, Vol. 29, 2000, p. 687.

Research output: Contribution to journalArticle

McColl, KEL, El-Omar, E & Gillen, D 2000, 'Helicobacter pylori gastritis and gastric physiology', Gastroenterology Clinics of North America, vol. 29, pp. 687.
McColl, K E L ; El-Omar, E ; Gillen, D . / Helicobacter pylori gastritis and gastric physiology. In: Gastroenterology Clinics of North America. 2000 ; Vol. 29. pp. 687.
@article{e6a794602c164de090b88e6be3e1d24c,
title = "Helicobacter pylori gastritis and gastric physiology",
abstract = "It is now recognized that Helicobacter pylori infection exerts profound and diverse effects on gastric acid secretory function and that the alterations in acid secretion depend on the pattern of gastritis caused by the infection. In patients with an antral predominant nonatrophic gastritis, there is acid hypersecretion leading to duodenal ulcer disease. In patients with an atrophic pangastritis, there is markedly reduced acid secretion and increased risk for gastric cancer. It is now recognized that acid secretion also modifies H. pylori gastritis and a person's premorbid acid secretory status may be an important factor in determining the pattern of gastritis that an individual develops. This two-way interaction between H. pylori gastritis and gastric acid secretion is important in understanding the role of H. pylori infection in the response to proton-pump inhibitor therapy: It explains the more profound control of gastric acid secretion in H. pylori-positive patients and why rebound acid hypersecretion is confined to H. pylori-negative subjects.",
keywords = "DUODENAL-ULCER PATIENTS, ACID SUPPRESSIVE THERAPY, NECROSIS-FACTOR-ALPHA, ANTRAL GASTRIN, INTRAGASTRIC PH, LONG-TERM, SOMATOSTATIN CONCENTRATIONS, CAMPYLOBACTER PYLORI, HEALTHY-SUBJECTS, IN-VITRO",
author = "McColl, {K E L} and E El-Omar and D Gillen",
year = "2000",
language = "English",
volume = "29",
pages = "687",
journal = "Gastroenterology Clinics of North America",
issn = "0889-8553",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Helicobacter pylori gastritis and gastric physiology

AU - McColl, K E L

AU - El-Omar, E

AU - Gillen, D

PY - 2000

Y1 - 2000

N2 - It is now recognized that Helicobacter pylori infection exerts profound and diverse effects on gastric acid secretory function and that the alterations in acid secretion depend on the pattern of gastritis caused by the infection. In patients with an antral predominant nonatrophic gastritis, there is acid hypersecretion leading to duodenal ulcer disease. In patients with an atrophic pangastritis, there is markedly reduced acid secretion and increased risk for gastric cancer. It is now recognized that acid secretion also modifies H. pylori gastritis and a person's premorbid acid secretory status may be an important factor in determining the pattern of gastritis that an individual develops. This two-way interaction between H. pylori gastritis and gastric acid secretion is important in understanding the role of H. pylori infection in the response to proton-pump inhibitor therapy: It explains the more profound control of gastric acid secretion in H. pylori-positive patients and why rebound acid hypersecretion is confined to H. pylori-negative subjects.

AB - It is now recognized that Helicobacter pylori infection exerts profound and diverse effects on gastric acid secretory function and that the alterations in acid secretion depend on the pattern of gastritis caused by the infection. In patients with an antral predominant nonatrophic gastritis, there is acid hypersecretion leading to duodenal ulcer disease. In patients with an atrophic pangastritis, there is markedly reduced acid secretion and increased risk for gastric cancer. It is now recognized that acid secretion also modifies H. pylori gastritis and a person's premorbid acid secretory status may be an important factor in determining the pattern of gastritis that an individual develops. This two-way interaction between H. pylori gastritis and gastric acid secretion is important in understanding the role of H. pylori infection in the response to proton-pump inhibitor therapy: It explains the more profound control of gastric acid secretion in H. pylori-positive patients and why rebound acid hypersecretion is confined to H. pylori-negative subjects.

KW - DUODENAL-ULCER PATIENTS

KW - ACID SUPPRESSIVE THERAPY

KW - NECROSIS-FACTOR-ALPHA

KW - ANTRAL GASTRIN

KW - INTRAGASTRIC PH

KW - LONG-TERM

KW - SOMATOSTATIN CONCENTRATIONS

KW - CAMPYLOBACTER PYLORI

KW - HEALTHY-SUBJECTS

KW - IN-VITRO

M3 - Article

VL - 29

SP - 687

JO - Gastroenterology Clinics of North America

JF - Gastroenterology Clinics of North America

SN - 0889-8553

ER -